Paediatric thrombo-embolism: The influence of non-genetic factors and the role of activated protein C resistance and protein C deficiency

被引:34
作者
UttenreutherFischer, MM
Vetter, B
Hellmann, C
Otting, U
Ziemer, S
Hausdorf, G
Gaedicke, G
Kulozik, AE
机构
[1] CHARITE VIRCHOW MED CTR,DEPT GEN PAEDIAT,D-13353 BERLIN,GERMANY
[2] CHARITE VIRCHOW MED CTR,INST PATHOL & CLIN BIOCHEM,D-10098 BERLIN,GERMANY
[3] CHARITE VIRCHOW MED CTR,DEPT PAEDIAT CARDIOL,D-10098 BERLIN,GERMANY
关键词
thrombosis; activated protein C resistance; protein C deficiency;
D O I
10.1007/s004310050600
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
In many children, the pathogenesis of thrombo-embolism remains unexplained. This study examines the role of non-genetic risk factors in 37 children with venous or arterial thrombosis. Included were 17 patients with portal vein thrombosis following umbilical vein catheterisation, 6 with portal vein thrombosis and an uneventful neonatal period, 4 with deep vein thrombosis, 4 with renal vein thrombosis after kidney transplantation, 1 haemodialysis patient with thromboses of arteriovenous shunts, and 5 with arterial thromboses at various sites. In 25 of these 37 patients (68%) exogenic risk factors and particularly vascular manipulations (24/ 37) were related to the thrombotic event. Resistance to activated protein C was identified in 5 patients and protein C deficiency in 2 (7/37; 19%). This prevalence was significantly higher than that of the control group (14/243; 5.8%; chi(2), P < 0.008). Conclusion Our data show that non-genetic and particular iatrogenic risk factors can often be identified in children with thrombosis, but activated protein C resistance and protein C deficiency are significant genetic risk factors in this age group.
引用
收藏
页码:277 / 281
页数:5
相关论文
共 24 条
[1]  
ANDREW M, 1994, HEMOSTASIS THROMBOSI, P989
[3]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[4]   HYPERCOAGULABILITY AND THROMBOSIS [J].
BICK, RL .
MEDICAL CLINICS OF NORTH AMERICA, 1994, 78 (03) :635-665
[5]  
BOVILL EG, 1989, BLOOD, V73, P712
[6]   FAMILIAL THROMBOPHILIA DUE TO A PREVIOUSLY UNRECOGNIZED MECHANISM CHARACTERIZED BY POOR ANTICOAGULANT RESPONSE TO ACTIVATED PROTEIN-C - PREDICTION OF A COFACTOR TO ACTIVATED PROTEIN-C [J].
DAHLBACK, B ;
CARLSSON, M ;
SVENSSON, PJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (03) :1004-1008
[8]   VENOUS THROMBOEMBOLIC COMPLICATIONS IN CHILDREN [J].
DAVID, M ;
ANDREW, M .
JOURNAL OF PEDIATRICS, 1993, 123 (03) :337-346
[9]   Hyperhomocysteinemia as a risk factor for deep-vein thrombosis [J].
denHeijer, M ;
Koster, T ;
Blom, HJ ;
Bos, GMJ ;
Briet, E ;
Reitsma, PH ;
Vandenbroucke, JP ;
Rosendaal, FR .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (12) :759-762
[10]  
GOBEL U, 1993, NEUROPEDIATRICS, V25, P4